Stonepine Capital Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,535,674
Closed -$27.4M 28
2023
Q1
$27.4M Buy
6,535,674
+1,601,574
+32% +$8.31M 9.21% 3
2022
Q4
$29.7M Sell
4,934,100
-735,288
-13% -$4.01M 12.47% 3
2022
Q3
$33M Buy
5,669,388
+1,988,193
+54% +$12.4M 14.83% 3
2022
Q2
$22M Sell
3,681,195
-1,003,209
-21% -$5.14M 10.23% 2
2022
Q1
$21.9M Sell
4,684,404
-4,115,954
-47% -$12.3M 9.07% 2
2021
Q4
$21.8M Buy
8,800,358
+836,029
+10% +$2.05M 10.02% 2
2021
Q3
$23.5M Buy
7,964,329
+331,799
+4% +$904K 10.69% 2
2021
Q2
$19.1M Buy
7,632,530
+4,339,111
+132% +$10.4M 9.98% 3
2021
Q1
$9.58M Buy
3,293,419
+1,239,419
+60% +$4.05M 5.18% 7
2020
Q4
$6.61M Sell
2,054,000
-1,714,597
-45% -$5.7M 5.06% 6
2020
Q3
$8.1M Sell
3,768,597
-299,594
-7% -$383K 8.43% 4
2020
Q2
$4.72M Sell
4,068,191
-2,362,446
-37% -$2.5M 9.14% 3
2020
Q1
$5.92M Buy
6,430,637
+2,675,637
+71% +$3.07M 6.26% 3
2019
Q4
$5.93M Buy
3,755,000
+43,001
+1% +$40.7K 4.14% 7
2019
Q3
$3.11M Sell
3,711,999
-192,401
-5% -$147K 3.02% 13
2019
Q2
$3.35M Sell
3,904,400
-95,600
-2% -$88.2K 2.31% 16
2019
Q1
$3.88M Sell
4,000,000
-1,726,579
-30% -$1.82M 2.23% 14
2018
Q4
$4.2M Buy
5,726,579
+424,516
+8% +$697K 3.69% 13
2018
Q3
$11.5M Buy
5,302,063
+1,252,765
+31% +$3.1M 6.7% 5
2018
Q2
$20.2M Sell
4,049,298
-1,092,448
-21% -$4.78M 12.25% 2
2018
Q1
$20.1M Buy
5,141,746
+3,306,908
+180% +$11.6M 10.75% 2
2017
Q4
$4.92M Buy
1,834,838
+841,838
+85% +$2.47M 2.95% 14
2017
Q3
$3.17M Sell
993,000
-1,291,381
-57% -$4.31M 1.87% 15
2017
Q2
$7.56M Buy
+2,284,381
New +$8.89M 4.08% 11
2017
Q1
Sell
-261,714
Closed -$1.07M 26
2016
Q4
$1.07M Buy
+261,714
New +$1.09M 0.64% 22
2016
Q2
Sell
-374,334
Closed -$1.99M 28
2016
Q1
$1.99M Sell
374,334
-695,528
-65% -$5.56M 2.35% 10
2015
Q4
$13.2M Buy
+1,069,862
New +$14.3M 15.42% 2

Other funds holding CTIC